Cargando…

Cardiac Pericytes: Underappreciated Targets of SARS-CoV-2

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Das, Mitali, Chung, Mina K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Leading Edge Translational Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970033/ https://www.ncbi.nlm.nih.gov/pubmed/36875780 http://dx.doi.org/10.1016/j.jacbts.2023.01.010

Ejemplares similares

Human Cardiac Pericytes Are Susceptible to SARS-CoV-2 Infection
por: Brumback, Brittany D., et al.
Publicado: (2022)

The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection
por: Beddingfield, Brandon J., et al.
Publicado: (2020)

Precision Medicine: Solving the Mystery of Myocarditis in the Aftermath of SARS-CoV-2
por: Feldman, Arthur M., et al.
Publicado: (2023)

An appropriate response to SARS
por: The Lancet Infectious Diseases
Publicado: (2003)

The use of chromoendoscopy for surveillance of inflammatory bowel disease
por: Lichtenstein, Gary R., et al.
Publicado: (2018)

Trade in wild animals: a disaster ignored
por: The Lancet Infectious Diseases
Publicado: (2003)

A European CDC
por: The Lancet Infectious Diseases
Publicado: (2003)

Making our hospitals healthier places
por: The Lancet Infectious Diseases
Publicado: (2004)

Original research in The Lancet Infectious Diseases
por: The Lancet Infectious Diseases
Publicado: (2010)

Are you ready for the next influenza pandemic?
por: The Lancet Infectious Diseases
Publicado: (2005)

A new public health world order
por: The Lancet Infectious Diseases
Publicado: (2004)

Empagliflozin Increases Cardiac Energy Production in Diabetes: Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors
por: Verma, Subodh, et al.
Publicado: (2018)

Empagliflozin Prevents Worsening of Cardiac Function in an Experimental Model of Pressure Overload-Induced Heart Failure
por: Byrne, Nikole J., et al.
Publicado: (2017)

Resolution of Inflammation Through the Lipoxin and ALX/FPR2 Receptor Pathway Protects Against Abdominal Aortic Aneurysms
por: Petri, Marcelo H., et al.
Publicado: (2018)

Neutrophil Subsets, Platelets, and Vascular Disease in Psoriasis
por: Teague, Heather L., et al.
Publicado: (2019)

Celecoxib Is Associated With Dystrophic Calcification and Aortic Valve Stenosis
por: Bowler, Meghan A., et al.
Publicado: (2019)

On Our Doorstep, A Precious Cargo From MSCs: The Role of Extracellular Vesicles in Stem Cell Therapy
por: Cooke, John P.
Publicado: (2020)

Rejuvenation of Senescent Endothelial Progenitor Cells by Extracellular Vesicles Derived From Mesenchymal Stromal Cells
por: Wang, Liyong, et al.
Publicado: (2020)

Integrating Integrins: A New Way to Increase Our COVID-19 Armamentarium?
por: Ross, Robert S.
Publicado: (2021)

Homophilic Interaction Between Transmembrane-JAM-A and Soluble JAM-A Regulates Thrombo-Inflammation: Implications for Coronary Artery Disease
por: Rath, Dominik, et al.
Publicado: (2022)

Jam-A Unleashed Incites Thromboinflammatory Coronary Artery Disease
por: Koenen, Rory R., et al.
Publicado: (2022)

PCSK9 Promotes Hypoxia-Induced EC Pyroptosis by Regulating Smac Mitochondrion-Cytoplasm Translocation in Critical Limb Ischemia
por: Zhang, Meixin, et al.
Publicado: (2023)

Assessment of Autophagy Markers Suggests Increased Activity Following LVAD Therapy
por: Martin, Thomas G., et al.
Publicado: (2023)

PCSK9-Inhibition to Quench Vascular Injury in Chronic Limb Threatening Ischemia
por: Okazaki, Ross, et al.
Publicado: (2023)

Autophagy in the LVAD-Supported Heart: A Sign of Hope or a Marker of Unloading
por: Rawnsley, David R., et al.
Publicado: (2023)

United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implications
por: Elliott, C. Gregory, et al.
Publicado: (2019)

Are anticoagulants still indicated in pulmonary arterial hypertension?
por: Olschewski, Horst, et al.
Publicado: (2018)

Early intervention: should we conduct therapeutic trials for mild pulmonary hypertension before onset of symptoms?
por: Huston, Jessica H., et al.
Publicado: (2019)

Extracellular vesicles released from p18 overexpressing pulmonary endothelial cells are barrier protective – potential implications for acute respiratory distress syndrome
por: Harrington, Elizabeth O., et al.
Publicado: (2020)

Pulmonary vasodilators: beyond the bounds of pulmonary arterial hypertension therapy in COVID-19
por: Franco, Veronica, et al.
Publicado: (2020)

Transplanting COVID-19–Positive Donor Hearts: A Previous Threat, Now an Opportunity
por: Schlendorf, Kelly H., et al.
Publicado: (2023)

Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells
por: Baig, Mirza S., et al.
Publicado: (2020)

The Essential Vulnerability of Human Cardiac Myocytes to SARS-CoV-2
por: Das, Mitali, et al.
Publicado: (2021)

Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2
por: Esposito, Susanna, et al.
Publicado: (2021)

Frontline Science: Shh production and Gli signaling is activated in vivo in lung, enhancing the Th2 response during a murine model of allergic asthma
por: Standing, Ariane S. I., et al.
Publicado: (2017)

IL‐4 induces a suppressive IL‐10‐producing CD8(+) T cell population via a Cdkn2a‐dependent mechanism
por: Zhao, Yapu, et al.
Publicado: (2013)

Frontline Science: Employing enzymatic treatment options for management of ocular biofilm‐based infections
por: Kugadas, Abirami, et al.
Publicado: (2019)

TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammation
por: McGrath, Emmet E., et al.
Publicado: (2011)

Frontline Science: TNF‐α and GM‐CSF1 priming augments the role of SOS1/2 in driving activation of Ras, PI3K‐γ, and neutrophil proinflammatory responses
por: Suire, Sabine, et al.
Publicado: (2019)

Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD
por: Burgueño, Juan F, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_om4us9e138g4r2n1v2amjd2gcu